Infectious Diseases & HIV Health Services; Director of the Implementation and Community Sciences Core @uabcfar ; aadiamd on 🦋posts my own
Birmingham, AL
Joined January 2019
- Tweets775
- Following814
- Followers721
- Likes24.9K
Aadia Rana MD retweeted
Full adherence to daily antiretroviral therapy for HIV can be challenging. In a phase 3b trial in Kenya, South Africa, and Uganda, a long-acting ART regimen was noninferior to daily ART use. Full IMPALA trial results and Research Summary: nej.md/4jWdqMY
ALT This image contains an excerpt from the Research Summary "Long-Acting HIV Therapy in African Adults with Adherence Challenges” published in the New England Journal of Medicine. It presents participant details: 540 adults, median age 40 years, 60% women, 40% men. To the right is a visual representation of a patient with human immunodeficiency virus who has adherence challenges to daily antiretroviral therapy. There are two treatment groups depicted with illustrations: one for intramuscular cabotegravir + rilpivirine with 271 participants, administered every 8 weeks (first 2 injection visits 4 weeks apart) and one for daily oral dolutegravir-based antiretroviral therapy with 269 participants. A prompt to read the full Research Summary at NEJM.org sits at the bottom.
Aadia Rana MD retweeted
The Panel updated the HIV treatment guidelines on Sept. 24, with revisions covering What to Start, Optimizing Antiretroviral Therapy, Adolescents and Young Adults With HIV, Substance Use Disorders, Women With HIV and more.
See what’s new: bit.ly/4je6gRB
Aadia Rana MD retweeted
HIV treatment has come a long way, but important questions remain. IDSA spokesperson and HIV researcher, Aadia Rana, MD, FIDSA (@AadiaMd) explains what researchers are working to understand next.
Watch the full press briefing: bit.ly/4h5UQAp
Aadia Rana MD retweeted
What happens to patients when HIV clinical trial funding is delayed? IDSA spokesperson and HIV researcher, Aadia Rana, MD, FIDSA (@AadiaMd) explains how the effects can be felt immediately.
Watch the full press briefing: bit.ly/4h5UQAp
Aadia Rana MD retweeted
Presented at #CROI2026 📣: #HIV infections would increase 📈 by 73% if the #RyanWhite HIV/AIDS Program ended.
vist.ly/4sxuy
Aadia Rana MD retweeted
🚨Prominent infectious disease expert calls #Florida slashing #HIV benefits to low-income residents “devastating.”
vist.ly/4tigy
Aadia Rana MD retweeted
Finalmente sale el estudio LATITUD, que demuestra que inyectables también son efectivos en el contexto de carga viral detectable. Felicidades a @AadiaMd y @ACTGNetwork gran estudio ✨
CAB/RPV for Persons with HIV and Adherence Challenges @NEJM nejm.org/doi/full/10.1056/NE…
Aadia Rana MD retweeted
In persons with HIV and barriers to adhering to antiretroviral therapy, a long-acting injectable treatment (monthly cabotegravir plus rilpivirine) resulted in better virologic control than standard oral ART. Full phase 3 LATITUDE trial results: nej.md/4qFyjMm
Editorial: From Efficacy to Access in Long-Acting HIV Therapy nej.md/4rRRyTT
ALT A figure showing the primary and key secondary outcomes.
Aadia Rana MD retweeted
Decades of rigorous and scientifically sound research have proven that vaccines do not cause autism. CDC’s decision to change language on its website reversing that finding is reckless and harmful.
Our statement w/ @HIVMA, @APIC, @SHEA_Epi & @SIDPharm: bit.ly/3XEc0KH
Aadia Rana MD retweeted
Currently available medications could be enough to end the #HIV epidemic in the US, provided people can access and afford them.
But the country needs more HIV docs. A lot more.
From #IDWeek2025 👇🏻
🗣️ With a perspective from @AadiaMd
healio.com/news/infectious-d…
Aadia Rana MD retweeted
Here's another interactive session you won't want to miss. Get involved in the discussion on long-acting HIV ART, common issues in HIV PrEP strategies and certain HIV opportunistic infections. IDWeek full program: bit.ly/48oDcnt
So excited to moderate this session - the mission and partnerships with public health to end the epidemic remain critical esp now and can’t wait to hear insights from @drdemetre, Clover Barnes DC Public Health, and Dazon Dixon Diallo Sister Love ATL. Join us on Wed at #IDWeek2025
Another HIV interactive session to add to your schedule for IDWeek: expect to get involved in discussions on ending the HIV epidemic, including ways to optimize HIV care in changing systems of law and public health and ways to engage key community populations in co-designing prevention and care strategies. Full IDWeek program here: bit.ly/48oDcnt
Aadia Rana MD retweeted
ACIP members are questioning whether the hepatitis B vaccine should continue to be universally administered to children at birth.
Fact: Implementation of universal birth dose hepatitis B vaccine is the most effective strategy to prevent childhood infections.
Aadia Rana MD retweeted
The puppies are coming BACK to #IDWeek2025! 🐶 Take a break in between sessions and play with some adorable (and adoptable!) dogs, provided by @furkidsinc.
This IDWeek experience is made possible by the generous support of GSK.
Register for IDWeek: idweek.org/registration
Aadia Rana MD retweeted
This decision — and other federal efforts to undermine well-established science about vaccine safety — puts everyone at risk, says IDSA President Tina Tan, MD, FIDSA, FPIDS, FAAP.
Our statement in response to the cancellation of the FDA meeting: idsociety.org/news--publicat…
Aadia Rana MD retweeted
25 hospitals are at risk of closing in Alabama if cuts go through-
Over 15 will likely close immediately.
88 percent of Rural Alabama Hospitals are in the red- they rely on federal funding.
Aadia Rana MD retweeted
Long-acting injectable ART is changing #HIV care for patients struggling with daily pills. The #LATITUDEStudy shows it can improve viral suppression—but challenges like insurance coverage remain. bit.ly/4gXrnoZ #HIVCare #LongActingART @AadiaMd
